Experiments on the efficacy and toxicity of locoregional chemotherapy of liver tumors with 5-fluoro-2'-deoxyuridine (FUDR) and 5-fluorouracil (5-FU) in an animal model. 1986

R Bartkowski, and M R Berger, and J L Aguiar, and T H Henne, and J Dörsam, and G H Geelhaar, and P Schlag, and C Herfarth

For the investigation of locoregional chemotherapy of liver neoplasms we developed a standardized animal model in the rat. Continuous infusion therapy or repeated bolus injections of FUDR or 5-FU were given via the hepatic artery, the portal vein or the vena cava in tumor-bearing animals. The efficacy of the treatment was determined by measuring the tumor volume 3 weeks after tumor cell implantation. For the evaluation of the local and systemic toxicity serum GOT, GPT, and total bilirubin were determined. DNA single strand breaks were assessed in isolated liver and bone marrow cells. Inhibition of colony formation of bone marrow stem cells was determined by CFU-C and CFU-S bioassay. A significant reduction of tumor growth was observed only after continuous infusion of FUDR via the hepatic artery. Systemic toxicity was lowest in this group for both compounds while the local liver toxicity was only slightly elevated.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008114 Liver Neoplasms, Experimental Experimentally induced tumors of the LIVER. Hepatoma, Experimental,Hepatoma, Morris,Hepatoma, Novikoff,Experimental Hepatoma,Experimental Hepatomas,Experimental Liver Neoplasms,Hepatomas, Experimental,Neoplasms, Experimental Liver,Experimental Liver Neoplasm,Liver Neoplasm, Experimental,Morris Hepatoma,Novikoff Hepatoma
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005467 Floxuridine An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract. FUdR,Fluorodeoxyuridine,5-FUdR,5-Fluorodeoxyuridine,5 Fluorodeoxyuridine
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

R Bartkowski, and M R Berger, and J L Aguiar, and T H Henne, and J Dörsam, and G H Geelhaar, and P Schlag, and C Herfarth
October 1963, Cancer chemotherapy reports,
R Bartkowski, and M R Berger, and J L Aguiar, and T H Henne, and J Dörsam, and G H Geelhaar, and P Schlag, and C Herfarth
July 1962, Archives of surgery (Chicago, Ill. : 1960),
R Bartkowski, and M R Berger, and J L Aguiar, and T H Henne, and J Dörsam, and G H Geelhaar, and P Schlag, and C Herfarth
December 1973, Journal of pharmaceutical sciences,
R Bartkowski, and M R Berger, and J L Aguiar, and T H Henne, and J Dörsam, and G H Geelhaar, and P Schlag, and C Herfarth
January 1990, Langenbecks Archiv fur Chirurgie,
R Bartkowski, and M R Berger, and J L Aguiar, and T H Henne, and J Dörsam, and G H Geelhaar, and P Schlag, and C Herfarth
January 1988, Journal of cancer research and clinical oncology,
R Bartkowski, and M R Berger, and J L Aguiar, and T H Henne, and J Dörsam, and G H Geelhaar, and P Schlag, and C Herfarth
November 1988, Pharmaceutical research,
R Bartkowski, and M R Berger, and J L Aguiar, and T H Henne, and J Dörsam, and G H Geelhaar, and P Schlag, and C Herfarth
February 1960, Cancer chemotherapy reports,
R Bartkowski, and M R Berger, and J L Aguiar, and T H Henne, and J Dörsam, and G H Geelhaar, and P Schlag, and C Herfarth
June 2001, Japanese journal of clinical oncology,
R Bartkowski, and M R Berger, and J L Aguiar, and T H Henne, and J Dörsam, and G H Geelhaar, and P Schlag, and C Herfarth
January 1990, Anticancer research,
R Bartkowski, and M R Berger, and J L Aguiar, and T H Henne, and J Dörsam, and G H Geelhaar, and P Schlag, and C Herfarth
January 2002, Nucleic acids research. Supplement (2001),
Copied contents to your clipboard!